litlas
Log inCreate account

R. Michael Blaese

Active 1964–2014

Also published as
R. MICHAEL BLAESE
86
Papers
20,285
Citations
82
h-index
86
i10-index

Citations

Citations per year for R. Michael Blaese1969: 3 citations1970: 1 citations1971: 4 citations1972: 12 citations1973: 8 citations1974: 18 citations1975: 26 citations1976: 30 citations1977: 25 citations1978: 45 citations1979: 29 citations1980: 45 citations1981: 49 citations1982: 31 citations1983: 21 citations1984: 38 citations1985: 34 citations1986: 38 citations1987: 37 citations1988: 54 citations1989: 26 citations1990: 44 citations1991: 75 citations1992: 66 citations1993: 82 citations1994: 141 citations1995: 147 citations1996: 189 citations1997: 164 citations1998: 183 citations1999: 180 citations2000: 233 citations2001: 143 citations2002: 158 citations2003: 119 citations2004: 115 citations2005: 76 citations2006: 84 citations2007: 81 citations2008: 48 citations2009: 48 citations2010: 50 citations2011: 65 citations2012: 51 citations2013: 82 citations2014: 33 citations2015: 55 citations2016: 55 citations2017: 62 citations2018: 43 citations2019: 140 citations2020: 133 citations2021: 134 citations2022: 78 citations2023: 84 citations2024: 96 citations2025: 30 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,737 citing papers, 44.5% of this breakdownUnited Kingdom: 308 citing papers, 7.9% of this breakdownGermany: 216 citing papers, 5.5% of this breakdownItaly: 169 citing papers, 4.3% of this breakdownFrance: 166 citing papers, 4.2% of this breakdownJapan: 128 citing papers, 3.3% of this breakdownCanada: 127 citing papers, 3.3% of this breakdownChina: 105 citing papers, 2.7% of this breakdownAustralia: 92 citing papers, 2.4% of this breakdownSweden: 74 citing papers, 1.9% of this breakdownNetherlands: 71 citing papers, 1.8% of this breakdownSwitzerland: 70 citing papers, 1.8% of this breakdown
0%44.5%Other 16.4%

Institutions

Fields

  • Medicine42%
  • Biochemistry, Genetics and Molecular Biology38.9%
  • Immunology and Microbiology15.6%
  • Neuroscience1.1%
  • Engineering0.5%
  • Materials Science0.4%
  • Other1.5%

Topics

  • Virus-based gene therapy research11.6%
  • CAR-T cell therapy research5.7%
  • RNA Interference and Gene Delivery5%
  • CRISPR and Genetic Engineering4.1%
  • Immune Cell Function and Interaction3.8%
  • Immunodeficiency and Autoimmune Disorders3.2%
  • Other66.6%

Coauthors

All papers

Open in search
  1. T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 Years

    Authors: R. Michael Blaese, Kenneth W. Culver, A. Dusty Miller, Charles S. Carter, Thomas A. Fleisher, Mario Clerici, Gene M. Shearer, Lauren A. Chang, Ya‐Wen Chiang, Paul Tolstoshev, Jay J. Greenblatt, Steven A. Rosenberg, Harvey G. Klein, Melvin Berger, Craig A. Mullen, W. Jay Ramsey, Linda Muul, Richard A. Morgan, W. French Anderson - Science 1995 cited by 1,519

  2. Gene Transfer into Humans — Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene Transduction

    Authors: Steven A. Rosenberg, Paul Aebersold, Kenneth Cornetta, Attan Kasid, Richard A. Morgan, Robert C. Moen, Evelyn M. Karson, Michael T. Lotze, James C. Yang, Suzanne L. Topalian, Maria J. Merino, Kenneth W. Culver, A. Dusty Miller, R. Michael Blaese, W. French Anderson - New England Journal of Medicine 1990 cited by 1,312

  3. Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.

    Authors: Robert Walker, Christine M. Bechtel, Ven Natarajan, Michael Baseler, Kristen Hege, Julia A. Metcalf, Randy Stevens, Allison Hazen, R. Michael Blaese, Clara C. Chen, Susan F. Leitman, Jolie Palensky, Janet Wittes, Richard T. Davey, Judith Falloon, Michael A. Polis, Joseph A. Kovacs, David Broad, Bruce L. Levine, Margo R. Roberts, Henry Masur, H. Clifford Lane - 2000 cited by 223

  4. Automatisiserte Erzeugung von Online-Lehreinheiten aus Tele-Veranstaltungen

    Authors: Kathleen E. Sullivan, Craig A. Mullen, R. Michael Blaese, Jerry A. Winkelstein - GI Jahrestagung (2) 1994 cited by 636

  5. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system.

    Authors: Craig A. Mullen, Mogens Kilstrup, R. Michael Blaese - National Academy of Sciences, Proceedings of the National Academy of Sciences 1992 cited by 505

  6. Improved Methods of Retroviral Vector Transduction and Production for Gene Therapy

    Authors: Hitoshi Kotani, Perry B. Newton, Shuyuan Zhang, Ya‐Wen Chiang, Edward Otto, Linda Weaver, R. Michael Blaese, W.F. Anderson, Gerard J. McGarrity - Human Gene Therapy 1994 cited by 375

  7. Wiskott-Aldrich Syndrome/X-Linked Thrombocytopenia: WASP Gene Mutations, Protein Expression, and Phenotype

    Authors: Qili Zhu, Chiaki Watanabe, Ting Liu, Diane Hollenbaugh, R. Michael Blaese, Steven B. Kanner, Alejandro Aruffo, Hans D. Ochs - Blood 1997 cited by 251

  8. Defective EBV-Specific Suppressor T-Cell Function in Rheumatoid Arthritis

    Authors: Giovanna Tosato, Alfred D. Steinberg, R. Michael Blaese - New England Journal of Medicine 1981 cited by 217

  9. Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis.

    Authors: Giovanna Tosato, A D Steinberg, Robert Yarchoan, C A Heilman, Sandra E. Pike, V De Seau, R. Michael Blaese - Journal of Clinical Investigation 1984 cited by 198

  10. Transfer of the HSV-tk Gene into Donor Peripheral Blood Lymphocytes for In Vivo Modulation of Donor Anti-Tumor Immunity after Allogeneic Bone Marrow Transplantation. The San Raffaele Hospital, Milan, Italy

    Authors: Claudio Bordignon, Chiara Bonini, Simona Verzeletti, Nadia Nobili, Daniela Maggioni, Catia Traversari, Raffaella Giavazzi, Paolo Servida, Elisabetta Zappone, E. Benazzi, Massimo Bernardi, Fulvio Porta, Giuliana Ferrari, Fulvio Mavilio, Silvano Rossini, R. Michael Blaese, Fabio Candotti - Human Gene Therapy 1995 cited by 149

  11. In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

    Authors: Kenneth W. Culver, Zvi Ram, Stuart Wallbridge, Hiroyuki Ishii, Edward H. Oldfield, R. Michael Blaese - Science 1992 cited by 1,527

  12. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

    Authors: Zvi Ram, Kenneth W. Culver, Eric M. Oshiro, John J. Viola, Hetty L. DeVroom, Edward Otto, Zhifeng Long, Ya‐Wen Chiang, Gerard J. McGarrity, Linda Muul, David Katz, R. Michael Blaese, Edward H. Oldfield - Nature Medicine 1997 cited by 683

  13. Persisting Illness and Fatigue in Adults with Evidence of Epstein-Barr Virus Infection

    Authors: Stephen E. Straus, GIOVANNA TOSATO, GARY ARMSTRONG, THOMAS LAWLEY, OLIVIA T. PREBLE, WERNER HENLE, RICHARD DAVEY, GARY PEARSON, JAY EPSTEIN, IRENA BRUS, R. MICHAEL BLAESE - Annals of Internal Medicine 1985 cited by 550

  14. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor.

    Authors: Craig A. Mullen, M M Coale, Rhiannon Lowe, R. Michael Blaese - 1994 cited by 223

  15. Acyclovir Treatment of the Chronic Fatigue Syndrome

    Authors: Stephen E. Straus, Janet K. Dale, Martin Tobi, Thomas J. Lawley, Olivia T. Preble, R. Michael Blaese, Claire W. Hallahan, Werner Henle - New England Journal of Medicine 1988 cited by 223

  16. Points to Consider Response with Clinical Protocol, July 6, 1990

    Authors: W. French Anderson, R. Michael Blaese, Kenneth W. Culver - Human Gene Therapy 1990 cited by 214

  17. Endonuclease Analysis of Viral DNA from Varicella and Subsequent Zoster Infections in the Same Patient

    Authors: Stephen E. Straus, William C. Reinhold, Holly A. Smith, William T. Ruyechan, David K. Henderson, R. Michael Blaese, John Hay - New England Journal of Medicine 1984 cited by 153

  18. Structural and Functional Basis for JAK3-Deficient Severe Combined Immunodeficiency

    Authors: Fabio Candotti, Scott A. Oakes, James A. Johnston, Silvia Giliani, Richard Fabian Schumacher, Patrizia Mella, Maurilia Fiorini, Alberto G. Ugazio, Raffaele Badolato, Luigi D. Notarangelo, Fabio Bozzi, Paolo Macchi, Dario Strina, Paolo Vezzoni, R. Michael Blaese, John J. O’Shea, Anna Villa - Blood 1997 cited by 142

  19. The bystander effect in the HSVtk/ganciclovir system and its relationship to gap junctional communication

    Authors: R. Touraine, H Ishii-Morita, WJ Ramsey, R. Michael Blaese - Gene Therapy 1998 cited by 109

  20. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.

    Authors: Zvi Ram, Kenneth W. Culver, Stuart Walbridge, R. Michael Blaese, Edward H. Oldfield - 1993 cited by 437

  21. Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction with the Thymidine Kinase Gene and Intravenous Ganciclovir. National Institutes of Health

    Authors: Edward H. Oldfield, Zvi Ram, Kenneth W. Culver, R. Michael Blaese, Hetty L. DeVroom, W. French Anderson - Human Gene Therapy 1993 cited by 417

  22. Gene therapy for cancer

    Authors: Kenneth W. Culver, R. Michael Blaese - Trends in Genetics 1994 cited by 243

  23. Gene therapy for adenosine deaminase–deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans

    Authors: Fabio Candotti, Kit L. Shaw, Linda Muul, Denise A. Carbonaro, Robert Sokolic, Christopher Choi, Shepherd H. Schurman, Elizabeth Garabedian, Chimene Kesserwan, G. Jayashree Jagadeesh, Pei-Yu Fu, Eric H. Gschweng, Aaron Cooper, John F. Tisdale, Kenneth I. Weinberg, Gay M. Crooks, Neena Kapoor, Ami J. Shah, Hisham Abdel‐Azim, Xiao-Jin Yu, Monika Smogorzewska, Alan S. Wayne, Howard M. Rosenblatt, Carla M. Davis, Celine Hanson, Radha Rishi, Xiaoyan Wang, David W. Gjertson, Otto O. Yang, Arumugam Balamurugan, Gerhard Bauer, Joanna A. Ireland, Barbara C. Engel, Gregory M. Podsakoff, Michael S. Hershfield, R. Michael Blaese, Robertson Parkman, Donald B. Kohn - Blood 2012 cited by 236

  24. The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene

    Authors: Qili Zhu, Miqin Zhang, R. Michael Blaese, JM Derry, Anne Junker, Uta Francke, S.-H. Chen, HD Ochs - Blood 1995 cited by 210